HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
NBTX
Nanobiotix
Healthcare Biotechnology ADR · France · Reports in eur
Market Cap: $1.63B
Market Cap
$1.63B
Enterprise Val
$1.68B
P/E Ratio
P/B Ratio
-16.37
Trailing PEG (1Y)
As Of
Apr 16, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$99.2M
Current Ratio1.09
Debt/Equity-1.13
LT Debt/Equity-1.08

Income Statement

Dec 31, 2025

Balance Sheet

Dec 31, 2025
Cash & Equivalents$62.1M
Accounts Receivable$2.5M
Inventory$0.00
Current Assets$73.8M
LT Investments$510.6K
Property, Plant & Equipment$5.4M
Intangibles$11.8K
Non-Current Assets$5.9M
Total Assets$79.7M
Accounts Payable$10.7M
Current Debt$5.1M
Current Liabilities$67.7M
LT Debt$107.1M
Non-Current Liabilities$111.5M
Total Liabilities$179.1M
Total Debt$112.1M
Retained Earnings-$471.5M
Shareholder Equity-$99.4M
Shares Outstanding48,236,671
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h